Villafaña is globally recognized as a “Living Legend of Medicine.” He is an award-winning USA Master Entrepreneur, a member of the Halls of Fame of Minnesota Business and Science & Technology.
Manny Villafaña is the Founder, Chairman, & CEO of Medical 21, Inc. (now part of Medtronic)Ĭo-inventor of the nitinol support and founder of Kips Bay Medical and Medical 21, Inc. This is the most commonly used prosthesis in the world.Ĭo-inventor of the ATS heart valve and founder of ATS Medical, Inc. All pacemakers now incorporate this technology.Ĭo-developer of the St. Villafaña will share the story of Medical 21 (his latest venture) and discuss fundraising goals and strategic partner interests.Ĭo-inventor of the first lithium powered pacemaker and founder of Cardiac Pacemakers, Inc./Guidant. Antoine is one of the few European and life science investors to have appeared on the prestigious list.Īt the Emerging Medtech Summit Dr. He has been selected twice for the Forbes Midas List, an annual ranking recognizing the world’s top venture capital investors. He has also invested in and is a board member of private companies Reflexion Medical, Tissium, Pi-Cardia, SafeHeal, Noema Therapeutics, Ablacare, Highlife and Inspirna (formerly Rgenix).Īntoine has an MBA from the Wharton School of Business, University of Pennsylvania. Trade sale success stories include CoreValve (sold to Medtronic), Fovea (sold to Sanofi Aventis), Ethical Oncology Science (EOS, sold to Clovis Oncology) and Recor Medical (sold to Otsuka). He has been an initial investor and active board member in a number of public companies, including Actelion, ProQR, Shockwave Medical, NovusPharma (sold to CTI), Movetis (sold to Shire), and Pixium Vision. When you find the right people to invest in, he adds, “you can bank on them more often than you can predict how the science is going to turn out.” He looks for entrepreneurs with the nimbleness to adapt, “even if that means a making a major shift from where one starts out on the journey.”Īntoine actively invests for our Capital Funds. Listening, discerning, negotiating, and finding common interests.”
#Simon halls net worth 2021 how to#
“Life Sciences investing is not just about recognizing good science,” Papiernik says, “it’s about people - learning how to interact with co-investors, limited partners, and entrepreneurs. Scott and his team at LSI have conducted numerous market research projects for top medical device manufacturers including Johnson & Johnson, Medtronic, Boston Scientific, Abbott, Becton Dickinson, Teleflex, Cardinal Health, GE Healthcare, and Stryker, among others.Īntoine Papiernik is Chairman and Managing Partner at Sofinnova Partners, which he joined in 1997.
He has held leadership roles as a strategic partner for Elsevier Business Intelligence, Health Research Intelligence, and Informa Business Intelligence. Prior to founding LSI, he held senior executive roles with renowned life science data providers including Medical Data International, Medtech Insight and Windhover Information. He has been in the medtech market intelligence business for over 20 years supporting venture funded startups, major strategics, and life science investors as they navigate the ever-changing medtech marketplace. Scott is the President, CEO and Founder of Life Science Intelligence. Scott's mission at the meeting will be to connect the investors, innovators and strategics that are driving the future of medtech. Scott will join his team of exclusive sponsors to host the Emerging Medtech Summit.
0 kommentar(er)
